B. Meister et al., Expression of vascular endothelial growth factor (VEGF) and its receptors in human neuroblastoma, EUR J CANC, 35(3), 1999, pp. 445-449
Angiogenic factors may play a role in the biology of neuroblastoma, a well
vascularised tumour, which frequently spreads haematogenously. Therefore, w
e analysed expression of vascular endothelial growth factor (VEGF) in six h
uman neuroblastoma cell lines and five primary neuroblastomas. High VEGF le
vels (1-3 ng/10(6) cells/day) were found in the supernatant of all cell lin
es examined (SK-N-LO, SK-N-SH, LS, SH-SY5Y, IMR-32, Kelly). VEGF peptide wa
s also detected in tissue homogenates from four of five primary tumours. Re
verse transcript ion-polymerase chain reaction (RT-PCR) revealed that VEGF(
165) is the major isoform produced by neuroblastomas. In addition, all cell
lines and primary tumours expressed the mitogenic VEGF receptor FLK-1, whi
lst the non-mitogenic receptor FLT-1 was less frequently positive, suggesti
ng that the tyrosine kinase FLK-1 is involved in malignant transformation o
f neuroblastoma cells. However, neutralising antibodies to VEGF did not inh
ibit growth of neuroblastoma cell lines, which argues against a role of VEG
F as an autocrine growth factor, at least for cell lines in vitro. We concl
ude that neuroblastoma cells produce VEGF, which may contribute to tumour v
ascularisation, growth and invasion. (C) 1999 Elsevier Science Ltd. All rig
hts reserved.